Introduction
Mammalian interleukin-7 (IL-7) is a cytokine involved in the regulation of lymphopoiesis, acting primarily on cells of the lymphoid lineage. IL-7 was originally defined by its ability to stimulate the proliferation of pre-B cells. Cells of the T cell lineage also respond to IL-7; both foetal and adult thymocytes of all surface phenotypes proliferate in response to IL-7 [1, 2] .
More recently it has become evident that IL-7 is a prototypic homeostatic cytokine, produced constitutively by non-lymphoid cells [3] . The mammalian IL-7 receptor (IL-7R) is composed of two chains: the IL-7Ra-chain (CD127) and a common g-chain (g c or CD132), shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21. IL-7Ra belongs to the type I cytokine receptor family. Structurally, two fibronectin-type III (FN) domains, four conserved cysteine residues and a WS motif in the extracellular domains characterise these receptors. The mature form of murine IL-7Ra consists of 439 amino acids (aa) and is a membrane glycoprotein with a single 25 aa transmembrane domain. The 195 aa cytoplasmic tail contains partially characterised regions; one region (A) that is rich in acidic residues, and one region (T) that contains three tyrosine residues that are conserved in mouse and man (Y401, Y449, and Y456 as numbered in the murine sequence).
In addition, a small membrane-proximal domain termed ''Box 1'' is conserved throughout the class I cytokine receptor family [4] .
Whereas the g c is expressed on most haematopoietic cells, IL7Ra is almost exclusively expressed on cells of the lymphoid lineage in which it has crucial functions (reviewed in [3, 5] ). IL-7 has emerged as a key cytokine involved in controlling the survival of peripheral resting T cells and their homeostatic turnover. The effect of IL-7 on T cells is controlled by the expression of the IL-7R, the state of differentiation of the cell, the availability of the cytokine and whether there is concomitant T cell receptor signalling (reviewed in [3, 5] ). Expression of IL-7Ra is a marker of naïve and memory T cells and it may serve to distinguish memory from effector T lymphocytes at early phases of the immune response [5] [6] [7] , especially when combined with the expression of CD62L. Cell subsets described as central memory T cells (CD127 hi and CD62L hi ) and peripheral effector memory T cells (CD127 hi and CD62L lo ) can be distinguished.
Moreover, surface expression of CD127 (IL-7Ra) combined with CD25 (IL-2Ra) can differentiate between human regulatory and conventional CD4+ T cells in adult peripheral blood [8] . CD127 lo T regulatory cells and CD127 hi conventional T cells can be distinguished within the CD25+ CD45RO+RAÀ effector/memory and CD25+ CD45RA+ROÀ naïve compartments. CD25+CD127 lo cells have suppressive activity in vitro whereas CD25+ CD127 hi cells do not [8] .
For the class I cytokine receptor family in the chicken, all of the common signalling chains have either been cloned and characterised [9, 10] or are present in the chicken genome sequence (reviewed in [11] ). IL-7 is encoded in the chicken genome and is expressed [12] . In the chicken, naïve, effector and memory T cells cannot be distinguished yet and the presence of regulatory T cells has not been demonstrated, but tools and assays to dissect T cell subsets are becoming available [13] . Here, we describe the cloning and expression of the chIL-7Ra and the development of a monoclonal antibody specific for chIL-7Ra, which will facilitate future research in chicken T cell development and discrimination between functional T cell subsets.
Materials and methods

Animals and tissues
To study mRNA expression of IL-7Ra, liver, spleen, thymus, bursa of Fabricius and bone marrow were collected from broiler chickens (Ross) at embryonic days 7 and 20 (ED7 and ED20; n = 4). Peripheral blood and spleens from 4-day-old to 6-week-old broiler chickens were used to sort cell subpopulations. Peripheral blood leukocytes (PBL) were isolated by density gradient centrifugation for 20 min at 850 Â g using FICOLL-Hypaque 1.078. Subpopulations of leukocytes were obtained after staining of cells with mouse anti-chicken CD4-PE (CT-4), CD8a-FITC (CT-8), CD8b-PE (EP42), and Bu-1-FITC (ChB6 clone AV20; Southern Biotechnology (SB), USA). Cells were sorted using a FACS Vantage SE instrument (Becton Dickinson). For every cell subpopulation at least 3 Â 10 4 PBL and 1 Â 10 6 splenocytes were analysed. For total RNA extractions, organs and cells were immediately immersed in RNAlater (Ambion) and stored at À20 8C until RNA was extracted.
Isolation of chicken IL-7Ra cDNA
Total RNA was extracted in the presence of buffer containing bmercaptoethanol and guanidine using an RNeasy Mini Kit (Qiagen)
following the manufacturer's instructions. RNA was eluted in 30 ml
RNase-free water and stored at À20 8C until required. The extracted RNA was reverse-transcribed using an iScript cDNA Synthesis Kit (Bio-Rad), with an oligo dT primer. All primers used for the PCR were designed to the EST sequence of chIL-7Ra in the chicken genome. Two primers, chIL-7R forward (5 0 -AGTATAAAGTCAGTGAGTGAGGGTTTC-3 0 ) and chIL-7R reverse (5 0 -AATAGAGAGCTTCAGTATCCAGCTTG-3 0 ) were designed outside the predicted chIL-7Ra coding sequence. To increase specificity of the PCR the first PCR product was used for a nested PCR. To obtain the full-length cDNA sequences for chIL-7Ra, two primers, chIL-7R-nested forward (5 0 -GGGGAATTCAGCATGCTCAGAATGACACG-3 0 ) and chIL-7R-nested reverse (5 0 -GGGTCTAGAAACGCCTACT-GATTTTTGTAAAAGC-3 0 ) were used in PCR. The forward primer contains an EcoRI restriction site at the 5 0 -end and the reverse primer contains a XbaI restriction site at the 3 0 -end. These restriction sites were used to ligate the PCR product into pCI-neo (Promega) and pcDNA3.1 myc-his (Invitrogen). Library-competent Escherichia coli DH5a cells (Invitrogen) were transfected with the plasmids using FuGene-6 Transfection Reagent (Roche) according to the manufacturer's protocol. Plasmid DNA was extracted with a Quantum Prep Plasmid Maxiprep Kit (Bio-Rad). The insert DNA was sequenced using the primers T7 promoter (5 0 -TAATACGACT-CACTATAGGG-3 0 ) and BGH-Reverse (5 0 -TAGAAGGCACAGTCGAGG-3 0 ) for pcDNA3.1 myc-his and T7EEV (5 0 -AAGGCTAGAGTACTTAA-TACGA-3 0 ) and T3 (5 0 -ATTAACCCTCACTAAAGGGA-3 0 ) for pCI-neo. Alignment of various IL-7Ra aa sequences was performed using the ClustalW Chicken FN_III domain prediction was performed using Pfam (http://www.sanger.ac.uk/software.pfam/). The growth factor and cytokine receptors family signature 2 (GFCRFS2) motif was predicted by Prosite motif search (http://www.expasy.ch/prosite). Similarity searches were performed using Blast Alignment (NCBI: http://www.ncbi.nlm.nig.gov/).
Chicken IL-7Ra expression analysis by real-time quantitative RT-PCR
IL-7Ra mRNA levels in different organs and cell subpopulations were quantified using real-time quantitative RT-PCR (qRT-PCR). For both cytokine receptor-(Accession No. EF116487) and 28S rRNA-specific amplification, primers and probes were designed using the Primer Express software program (PE Applied Biosystems). Details of probes and primers are given in Table 1 .
QRT-PCR was performed using the TaqMan Universal PCR Master Mix (PE Applied Biosystems). Amplification and detection of specific products were performed using the ABI PRISM 7700 Sequence Detection System (PE Applied Biosystems) with the following amplification profile: 1 cycle of 50 8C for 2 min, 95 8C for 10 min and 40 cycles of 95 8C for 20 s, 59 8C for 1 min. Primers were used at 600 nM and probes at 100 nM. Quantification was based on the increased fluorescence detected by the ABI-PRISM 7700 Sequence Detection System due to hydrolysis of the target-specific probes by the 5 0 nuclease activity of the AmpliTaq Gold DNA Polymerase during PCR amplification. A passive reference dye ROX (present in the TaqMan Universal PCR Master Mix), which is not involved in amplification, was used to correct for fluorescent fluctuations resulting from changes in the reaction conditions, for normalisation of the reporter signal.
Results are expressed in terms of the threshold cycle value (Ct), the cycle at which the change in reporter dye passes the significance threshold (DRn). Corrections for variations in RNA preparation and sampling were performed according to Eldaghayes et al. [14] . Results were then expressed as 40-Ct.
Expression chIL-7Ra on leukocytes
Two Balb/c mice were immunised three times with 50 mg plasmid DNA, pCI-neo-chIL-7Ra, at three-week intervals. After Table 1 Real-time qRT-PCR probes and primers.
RNA target
Probe/primer sequence (5 three weeks, mice were boosted with 2 Â 10 7 chicken thymocytes.
Hybridomas were generated by fusion of splenic lymphocytes, two weeks after the last boost, with mouse myeloma Sp2/0-Ag14 cells, according to the method of Segers et al. [15] . After fusion, the cells were distributed in flat-bottomed 96-well plates. Supernatants from wells containing growing colonies were tested by indirect immunofluorescence on chicken PBL and measured by flow cytometry. The second round of selection also included reactivity on spleen cryosections using immunohistochemistry [16] and on COS cells expressing recombinant chIL-7Ra. Positive wells were cloned by single cell limiting dilution on the FACSVantage cell sorter (BD Biosciences, San Jose, CA) using CellQuest software (BD Biosciences). Immunoglobulin subclass was determined using a Beadlyte Mouse Immunoglobulin Isotyping Kit (Upstate) using the Luminex 100 System. IL-7Ra expression at the protein level was measured on PBL and splenocytes from Heisdorf & Nelson Silver Nick layer birds of one, three and six weeks of age. Blood was diluted in pre-warmed Fig. 2 . Comparison of amino acid sequences between chicken IL-7Ra and human, mouse, dog, cow and zebrafish IL-7Ra (Accession numbers EF116487, NP_002176, EDL03312, XP_855408, XP_599818 and NP_001106979 respectively). The predicted Fn_III domain is underlined. The conserved GFCRFS2 (growth factors and cytokine receptors family signature 2) domain (GXWSXWS motif) in the Fn_III domain is overlined and annotated. The predicted trans-membrane domain is double-underlined. In the cytoplasmic tail, a small membrane-proximal domain, termed ''Box 1'' (Val 277 to His 284 ) is also overlined and annotated. A conserved 11 aa motif at the COOH-terminal of the protein, containing two tyrosine residues (Tyr  450 and Tyr   457 ), is double-overlined.
Hanks Balanced Salt Solution and lymphocytes purified after slowspin centrifugation (62 Â g, 20 min, RT). PBL and splenocytes were triple-stained with mouse anti-chicken IL-7Ra and goat antimouse (IgM)-APC (SB), fluorescein (FITC)-labeled or phycoerythrin (PE)-labeled mouse anti-chicken CD8a, CD8b, CD4, ChB6 (Bu-1-FITC), or KUL01-FITC (monocyte/macrophages; SB) and with T cell receptor-specific antibodies TCR-gd-FITC (TCR1), TCR-ab1-FITC (TCR2), or TCR-ab2-FITC (TCR3; SB). Cells were acquired on a FACSCalibur flow cytometer (BD Biosciences) and analysed using CellQuest software.
Splenocytes were stimulated for 24 h at 41 8C with 5 or 10 mg/ ml ConA or medium (RPMI-1640, 5% FCS, penicillin, streptomycin) and triple-stained for chIL-7Ra and T cell markers as described above.
Immunocytochemical stainings were performed on cryosections of spleen and thymus. Sections were acetone fixed and incubated with monoclonal antibodies specific for chIL-7Ra (biotin labeled) and ChB6 (Bu-1), CD4, CD8a, CD8b, TCR-ab1, TCRab2, TCR-gd or KUL01 (monocytes and macrophages). Slides were washed and incubated with avidin-enzyme complex (Vectastain 1 Elite ABC kit) and goat anti-mouse IgG-AP. Alkaline phosphatase activity was developed with Fast Blue BB salt and then the peroxidase activity was developed with AEC [17] .
Results
Cloning and characterisation of full length chIL-7Ra
Using a PCR-based approach with primers designed to the predicted sequence in the chicken genome, we cloned the CHIL7Ra chain cDNA (Fig. 1) . The predicted protein sequence of chIL7Ra contained 460 aa residues (Fig. 1 
Expression of chIL-7Ra mRNA
Quantification of RNA levels was performed using real-time qRT-PCR and normalised against 28S rRNA expression levels. Expression of chIL-7Ra mRNA was analysed in organs of ED20 embryos and in chickens post-hatch (Fig. 3A) . In both embryos and chickens post-hatch, expression was seen in all organs, with highest levels of chIL-7Ra mRNA detected in lymphoid organs which contain a high number of T cells. Expression of chIL-7R mRNA was detected as early as ED7 in pooled lymphoid organs and in the yolk sac, though expression levels were lower than at ED20 (data not shown). Lymphocyte subpopulations from blood and spleen of 6-week-old birds were sorted and analysed (Fig. 3B) . In the spleen, expression of chIL-7Ra did not vary much between chickens and significantly higher expression of chIL-7Ra mRNA was found in T cells compared to B cells (p < 0.05).
Expression of chIL-7Ra on leukocytes
After several rounds of selection, one hybridoma (8F10E11) was selected that reacted with PBL using flow cytometry, on cryosections of spleen using immunohistochemistry, and on transfected COS cells. This clone was found to be secreting an IgM antibody with a kappa light chain and was used for further characterisation and expression of chIL-7Ra on leukocytes.
Age-related expression of chIL-7Ra was determined on PBMC and splenocytes of birds of one, three and six weeks of age. Although chB6+ B cells expressed chIL-7Ra at the mRNA level, the percentage of chB6+ B cells that expressed the protein at the membrane surface was very low (<1%; data not shown). On monocytes and macrophages (KUL01+ cells), chIL-7Ra expression was also rare (<1%; data not shown). No changes with age in blood and spleen were found for either cell population.
T cells were triple-stained for chIL-7Ra; CD4, CD8a or CD8b; and T cell receptors (Fig. 4A) . In peripheral blood, 90% of the CD4+ cells expressed chIL-7Ra of which 70-75% were TCR-ab1+ (TCR2) and 25-30% TCR-ab2+ (TCR3). In the spleen, 70-80% of the CD4+ cells expressed chIL-7Ra, with a similar distribution of the TCRs as on CD4+ cells in blood. ChIL-7Ra was not preferentially expressed on TCR-ab1+ or on TCR-ab2+ cells. The percentage of CD4+ cells that expressed chIL-7Ra in both blood and spleen was not significantly affected by age.
In peripheral blood, the percentage of CD8a+ cells expressing chIL-7Ra decreased with age from 60% to 30%. Of the CD8a+ IL-7Ra+ cells in blood, 75% of cells co-expressed TCR-ab1 and 25% TCR-ab2, with no significant changes with age. Fewer than 1% of the cells were TCR-gd+ (data not shown). In the spleen the percentage of CD8a+ cells that expressed chIL-7Ra was much lower than in blood, but a similar decrease with age was found, ranging from 30% to 10%. With age the percentage of CD8a+ chIL-7Ra+ cells that co-expressed TCRab1 decreased whereas the percentage of cells that co-expressed TCR-ab2 increased. The percentage of CD8a+ chIL-7Ra+ TCR-gd+ cells was higher in the spleen than in the blood, increasing from 1% to 10% with age (data not shown).
CD8a expression could be subdivided into high and intermediate expression (Fig. 4B) . The expression of chIL-7Ra in blood and spleen was mostly confined to the CD8a int cells. These CD8a cells rarely expressed CD8b, which was in sharp contrast to the expression of chIL-7Ra at the mRNA level. Changing the order in which the monoclonal antibodies were used to stain the cells did not affect the result, suggesting that the lack of staining of CD8b+ cells was not due to steric hindrance of the monoclonal antibodies that were used. Splenocytes were stimulated with a polyclonal T cell stimulus, ConA, in order to study changes in expression of chIL-7Ra upon activation. Stimulation for 24 h resulted in a tremendous downregulation of chIL7Ra on CD4+ and only a slight down-regulation on CD8a+ T cells (Fig. 5) . The number of CD4+ and CD8a+ cells increased after stimulation and the geometric MFI of CD4+ and CD8a+ cells slightly decreased (data not shown).
The expression of chIL-7Ra in thymus and spleen was studied using immunocytochemistry. Cortical thymocytes mainly represent double-positive cells expressing both CD4 and CD8. ChIL-7Ra was expressed on most cortical thymocytes except for the outer 2-5 cell layers in the subcapsular sinus, where the differentiation of the precursor cells starts. These thymocytes do not express CD4 or CD8. During migration from the cortex to the medulla, the thymocytes mature into single-positive T cells [18] . In the medulla most CD4+ and CD8+ cells co-expressed chIL-7Ra. Differences in staining were found when cells were stained for TCR-gd and TCRab1 (TCR1 and TCR2 respectively). Almost all ab1-TCR+ cells coexpressed IL-7Ra in the medulla, but many TCR-gd+ cells did not co-express chIL-7Ra (Fig. 6A) . In the spleen, the FACS analysis results were confirmed. Many CD4+ cells but fewer CD8a+ cells coexpressed chIL-7Ra, whereas most TCR-ab1+ cells also coexpressed IL-7Ra (Fig. 6B) . Few TCR-gd+ cells expressed the chIL-7Ra (Fig. 6) .
Discussion
Herein we describe the cloning, characterisation, and expression patterns of the chicken IL-7Ra. Like mammalian IL-7Ra, the chIL-7Ra protein sequence contains a GXWSXWS motif located in the FN_III domain. This motif is conserved among type I cytokine receptor family members. Moreover, a small membrane proximal domain termed ''Box 1'' (Val 277 to His 284 ) and an 11 aa motif containing two tyrosine residues (Tyr 450 and Tyr 457 ) were also conserved. All these features strongly suggested that the cDNA described in this paper encodes the alpha chain of chIL-7R. The estimated molecular mass of chIL-7Ra was 52.2 kDa.
The IL-7R consists of two components, the IL-7Ra and a gc. Both chains are essential for the biological effects of IL-7 [19] , as homodimerisation of chimeric IL-7Ra is not sufficient for signalling [20] . The model of IL-7R signalling is presumed to resemble that of other gc family cytokines, with IL-2Rb being best studied [21, 22] . IL-7 first binds to IL-7Ra and then recruits gc, bringing together their intracellular domains bearing Jak1 and Jak3. After mutual phosphorylation, these kinases acquire much higher activity and phosphorylate the critical Y449 (as numbered in the murine sequence) site on the IL-7Ra. This site binds STAT5 and possibly other adaptors and in turn becomes phosphorylated by Jak1 and/or Jak3. Jiang et al. [23] showed that deletion of Box 1 eliminated Jak1 phosphorylation and mutation of Y449 eliminated STAT5 phosphorylation. Both Box 1 and Y449 played a critical role in generation of thymocytes in vivo [23] . The chIL-7Ra also contains a Box 1 domain and a tyrosine-containing motif with two tyrosines (Y450 and Y457) with conserved spacing between them when compared to the same motifs in mammalian and fish IL-7Ra. Though not proven, based on the sequence homology of the IL-7Ra it is likely that these signalling pathways will be conserved in the chicken, especially as Jak1, Jak3 and STAT5 are all present in the chicken genome.
In the chicken, IL-7Ra mRNA expression in primary and secondary lymphoid organs of embryos increased during development (data not shown) and at ED20 high mRNA expression levels were seen, especially in lymphoid organs rich in T cells. In splenic cell subpopulations, the highest mRNA expression levels were seen in T cell subpopulations, in CD4+, CD8a+ and CD8b+ cells, which coincides with the expression pattern of the IL-7Ra in mammals.
Subsequently, expression of the chIL-7Ra protein was investigated on PBMC and splenocytes using a newly developed monoclonal antibody, 8F10E11. In blood, most CD4+ cells expressed chIL7Ra independent of the age of the birds. In contrast, the percentage of CD8a+ cells expressing chIL-7Ra in blood decreased with increasing age. On these cells chIL-7Ra was mostly expressed on In chickens, CD8aa homodimers have to date been described on NK cells [24] and intestinal intraepithelial lymphocytes [25] . In mice, CD8aa is constitutively expressed on intraepithelial lymphocytes [26] , but not uniquely on mucosal T cells. CD8aa is not expressed on resting naïve T cells in the periphery, but coexpression of CD8aa and CD8ab on activated conventional T cells has been reported [27, 28] . The induction of CD8aa on primary effector cells in vivo is not an activation marker, but CD8aa plays a role during initial survival and differentiation of the memory precursor. Consistent with memory precursors, these CD8aa+ cells co-expressed high levels of IL-7R, which is characteristic for memory T cells and their predecessors [29, 30] . Using cytotoxic T cell lines, the expression of both CD8 isoforms was shown to be differentially regulated. In response to TCR activation in vitro CD8ab is down-regulated and internalised together with the activated TCR, whereas CD8aa is up-regulated [30] . Although it is unclear as to what occurs to CD8 isoforms upon TCR stimulation in the chicken, the CD8aa+ cells in blood and spleen are relatively more intracellular IFN-g + than the CD8a hi + population [13] , which could indicate that these cells have a memory or predecessor phenotype in the chicken too. Luhtala et al. [31] demonstrated that chicken CD4+ CD8aa+ cells are functionally normal T cells, since they proliferate in response to mitogens and signals delivered via the TCR-ab as well as via the CD28 co-receptor.
In mammals, IL-7Ra transcription is suppressed in response to IL-7, to other pro-survival cytokines (IL-2, IL-4, IL-6, and IL-15) and upon antigen encounter. Consequently, IL-7R expression is reduced and these T cells undergo massive clonal proliferation and differentiation into effector cells, and do not compete with unstimulated T cells for any remaining IL-7. Chicken splenocytes were polyclonally stimulated with ConA and the expression of chIL-7Ra decreased significantly thereafter. Considering that the number of CD4+ and CD8a+ cells increased after stimulation and the geometric MFI of CD4+ and CD8a+ staining slightly decreased, the down-regulation of chIL7Ra cell surface expression was unlikely to be due to loss of CD4+ and CD8a+ cells.
The immunocytochemical data confirmed the chIL-7Ra expression patterns shown by FACS analysis, indicating that we developed a useful tool to detect chicken IL-7Ra that can be applied in different techniques, thereby expanding the chicken's ''immunological toolbox''. Future research will focus on chicken T cell development and discrimination between functional T cell subsets.
